Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 2 institutions in 2 countries.
Elisabete TeixeiraCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.ORCID 0000-0002-2133-6369
Cláudia FernandesCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.
Maria BungărdeanDepartment of Pathology, Iuliu Haţieganu University of Medicine and Pharmacy, Municipal Clinical Hospital, Cluj-Napoca 400139, Romania.ORCID 0000-0002-3090-5826
Arnaud Da Cruz PaulaCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.
Raquel T LimaCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.ORCID 0000-0002-5838-9659
Rui BatistaCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.
João VinagreCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.ORCID 0000-0002-0871-1427
Manuel Sobrinho-SimõesCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.
Valdemar MáximoCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.ORCID 0000-0002-8631-8356
Paula SoaresCancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.ORCID 0000-0001-9607-6998
Universidade do Porto · PTIuliu Hațieganu University of Medicine and Pharmacy · RO
Funding
Institutional Career Development CoreKL2TR001862 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$12.2M
NCATS NIH HHS KL2 TR001862
6 · The paper itself
Abstract
In a family with Familial Non-Medullary Thyroid Carcinoma (FNMTC), our investigation using Whole-Exome Sequencing (WES) uncovered a novel germline
Indexed as
Thyroid Cancer, PapillaryThyroid NeoplasmsUbiquitin-Specific ProteasesCaspase 3Genetic Predisposition to DiseaseHumansMutationThiolester HydrolasesTumor Suppressor Protein p53Caspase 3Thiolester HydrolasesTumor Suppressor Protein p53Ubiquitin-Specific ProteasesUSP13 protein, humanUSP42 protein, humanFamilial Non-Medullary Thyroid Carcinomafamilial thyroid cancerhereditary cancermolecular studiesubiquitination
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.